Latest News & Features
Big Pharma
UK-based Horizon Discovery has entered into a CRISPR collaboration with an unnamed big pharma company. 29 August 2018
Americas
Purdue Pharma has settled another patent dispute involving pain drug OxyContin (oxycodone), just weeks after a suit against generics company Amneal Pharmaceuticals came to an end. 29 August 2018
Big Pharma
Late last week, Chugai Pharmaceutical emerged victorious after the English High Court found that the Japan-based company doesn’t owe royalties under a patent licence with UCB. 28 August 2018
Americas
Generics maker Alvogen secured a patent win at a US court last week, despite the judge finding that the company had infringed patents covering an opioid treatment. 28 August 2018
Americas
A Wisconsin jury has concluded that medical device company DePuy Synthes should pay $8.2 million for wilfully infringing an orthopaedic implant patent. 27 August 2018
Asia-Pacific
York Faulkner, an IP partner from Finnegan, Henderson, Farabow, Garrett & Dunner, has joined Quinn Emanuel Urquhart & Sullivan in Tokyo. 24 August 2018
Big Pharma
The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market. 24 August 2018
Americas
A non-profit called AIDS Healthcare Foundation has filed a petition for certiorari with the US Supreme Court in a patent dispute with Gilead. 23 August 2018
Big Pharma
Danish healthcare company Novo Nordisk has entered into an alliance with Germany-based Evotec to develop treatments for diabetes and obesity. 23 August 2018
Big Pharma
Pharmaceutical company AbbVie has signed an exclusive licensing agreement with biotech group Argenx to develop and commercialise immuno-oncology antibody ARGX-115. 23 August 2018